These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17724464)

  • 1. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
    Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
    Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax.
    Werner AB; de Vries E; Tait SW; Bontjer I; Borst J
    J Biol Chem; 2002 Jun; 277(25):22781-8. PubMed ID: 11929871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis.
    Clohessy JG; Zhuang J; de Boer J; Gil-Gómez G; Brady HJ
    J Biol Chem; 2006 Mar; 281(9):5750-9. PubMed ID: 16380381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.
    Willis SN; Chen L; Dewson G; Wei A; Naik E; Fletcher JI; Adams JM; Huang DC
    Genes Dev; 2005 Jun; 19(11):1294-305. PubMed ID: 15901672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
    Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BH3-only proteins Noxa, Bik, Bmf, and Bid activate Bax and Bak indirectly when studied in yeast model.
    Gérecová G; Kopanicová J; Jaká P; Běhalová L; Juhásová B; Bhatia-Kiššová I; Forte M; Polčic P; Mentel M
    FEMS Yeast Res; 2013 Dec; 13(8):747-54. PubMed ID: 23991648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1.
    Zhai D; Jin C; Huang Z; Satterthwait AC; Reed JC
    J Biol Chem; 2008 Apr; 283(15):9580-6. PubMed ID: 18178565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak.
    Uren RT; Dewson G; Chen L; Coyne SC; Huang DC; Adams JM; Kluck RM
    J Cell Biol; 2007 Apr; 177(2):277-87. PubMed ID: 17452531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization.
    Meng XW; Lee SH; Dai H; Loegering D; Yu C; Flatten K; Schneider P; Dai NT; Kumar SK; Smith BD; Karp JE; Adjei AA; Kaufmann SH
    J Biol Chem; 2007 Oct; 282(41):29831-46. PubMed ID: 17698840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BH3-only protein bid participates in the Bcl-2 network in healthy liver cells.
    Hikita H; Takehara T; Kodama T; Shimizu S; Hosui A; Miyagi T; Tatsumi T; Ishida H; Ohkawa K; Li W; Kanto T; Hiramatsu N; Hennighausen L; Yin XM; Hayashi N
    Hepatology; 2009 Dec; 50(6):1972-80. PubMed ID: 19839062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
    Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC
    Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis.
    Huang K; O'Neill KL; Li J; Zhou W; Han N; Pang X; Wu W; Struble L; Borgstahl G; Liu Z; Zhang L; Luo X
    Cell Res; 2019 Nov; 29(11):942-952. PubMed ID: 31551537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak.
    Zhai D; Luciano F; Zhu X; Guo B; Satterthwait AC; Reed JC
    J Biol Chem; 2005 Apr; 280(16):15815-24. PubMed ID: 15661737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.
    Gillissen B; Essmann F; Hemmati PG; Richter A; Richter A; Oztop I; Chinnadurai G; Dörken B; Daniel PT
    J Cell Biol; 2007 Nov; 179(4):701-15. PubMed ID: 18025305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of staurosporine-induced activation of the proapoptotic multidomain Bcl-2 proteins Bax and Bak by three invasive chlamydial species.
    Zhong Y; Weininger M; Pirbhai M; Dong F; Zhong G
    J Infect; 2006 Dec; 53(6):408-14. PubMed ID: 16490255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bcl-2-associated death promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondria disintegration.
    Howells CC; Baumann WT; Samuels DC; Finkielstein CV
    J Theor Biol; 2011 Feb; 271(1):114-23. PubMed ID: 21130780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-2-family protein tBID can act as a BAX-like effector of apoptosis.
    Flores-Romero H; Hohorst L; John M; Albert MC; King LE; Beckmann L; Szabo T; Hertlein V; Luo X; Villunger A; Frenzel LP; Kashkar H; Garcia-Saez AJ
    EMBO J; 2022 Dec; 41(2):e108690. PubMed ID: 34931711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.
    Gillissen B; Wendt J; Richter A; Richter A; Müer A; Overkamp T; Gebhardt N; Preissner R; Belka C; Dörken B; Daniel PT
    J Cell Biol; 2010 Mar; 188(6):851-62. PubMed ID: 20308427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.